Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ADVM-022
ADVM-022
Half of Adverum pipeline 'snaps out of existence' as adverse events force pivot to more common eye disease
Fierce Biotech
Fri, 07/23/21 - 11:07 am
Adverum Biotechnologies
ADVM-022
diabetic macular edema
gene therapy
3 Soaring Biotech Stocks to Watch in December
Motley Fool
Mon, 12/2/19 - 10:40 am
Arrowhead Pharmaceuticals
RNAi
Adverum Biotechnologies
gene therapy
ADVM-022
Arqule
ARQ-531
Early snapshot of Adverum's eye gene therapy sparks concern about vision loss
Endpoints
Sat, 09/14/19 - 11:25 am
Adverum Biotechnologies
wet age-related macular degeneration
gene therapy
ADVM-022
Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study
Yahoo/Zacks.com
Tue, 05/21/19 - 09:35 am
Adverum Biotechnologies
FDA
clinical trials
ADVM-022
wet age-related macular degeneration
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 05/19/19 - 04:02 pm
Adverum Biotechnologies
ADVM-022
Iovance
LN-145
cervical cancer
MeiraGTx
AAV-RPE65
Adverum Biotechnologies Announces Positive Results in Preclinical Study of ADVM-022 Gene Therapy in Wet AMD
CP Wire
Tue, 05/1/18 - 11:15 am
Adverum Biotechnologies
ADVM-022
wet age-related macular degeneration
